Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Therapeutic potential of cinnoline core: A comprehensive review.

Tonk RK, Bawa S, Kumar D.

Mini Rev Med Chem. 2019 Oct 10. doi: 10.2174/1389557519666191011095858. [Epub ahead of print]

PMID:
31660825
2.

Development of Thiazole-5-carboxylate Derivatives as Selective Inhibitors of Monoacylglycerol Lipase as Target in Cancer.

Ali MR, Kumar S, Shalmali N, Afzal O, Azim S, Chanana D, Alam O, Paudel YN, Sharma M, Bawa S.

Mini Rev Med Chem. 2019;19(5):410-423. doi: 10.2174/1389557518666180702103542.

PMID:
29962341
3.
4.

2-[(4-Chlorobenzyl) amino]-4-methyl-1,3-thiazole-5-carboxylic acid exhibits antidiabetic potential and raises insulin sensitivity via amelioration of oxidative enzymes and inflammatory cytokines in streptozotocin-induced diabetic rats.

Paudel YN, Ali MR, Shah S, Adil M, Akhtar MS, Wadhwa R, Bawa S, Sharma M.

Biomed Pharmacother. 2017 May;89:651-659. doi: 10.1016/j.biopha.2017.02.043. Epub 2017 Mar 3.

PMID:
28262618
5.

Imidazole: An Essential Edifice for the Identification of New Lead Compounds and Drug Development.

Shalmali N, Ali MR, Bawa S.

Mini Rev Med Chem. 2018;18(2):142-163. doi: 10.2174/1389557517666170228113656. Review.

PMID:
28245779
6.

2-Benzamido-4-methylthiazole-5-carboxylic Acid Derivatives as Potential Xanthine Oxidase Inhibitors and Free Radical Scavengers.

Ali MR, Kumar S, Afzal O, Shalmali N, Ali W, Sharma M, Bawa S.

Arch Pharm (Weinheim). 2017 Feb;350(2). doi: 10.1002/ardp.201600313. Epub 2017 Jan 30.

PMID:
28133790
7.

Hit to lead optimization of a series of N-[4-(1,3-benzothiazol-2-yl)phenyl]acetamides as monoacylglycerol lipase inhibitors with potential anticancer activity.

Afzal O, Akhtar MS, Kumar S, Ali MR, Jaggi M, Bawa S.

Eur J Med Chem. 2016 Oct 4;121:318-330. doi: 10.1016/j.ejmech.2016.05.038. Epub 2016 May 21.

PMID:
27267002
8.

Development of 2-(Substituted Benzylamino)-4-Methyl-1, 3-Thiazole-5-Carboxylic Acid Derivatives as Xanthine Oxidase Inhibitors and Free Radical Scavengers.

Ali MR, Kumar S, Afzal O, Shalmali N, Sharma M, Bawa S.

Chem Biol Drug Des. 2016 Apr;87(4):508-16. doi: 10.1111/cbdd.12686. Epub 2015 Dec 16.

PMID:
26575582
9.

3D-QSAR study of benzotriazol-1-yl carboxamide scaffold as monoacylglycerol lipase inhibitors.

Afzal O, Kumar S, Kumar R, Jaggi M, Bawa S.

J Pharm Bioallied Sci. 2014 Oct;6(4):260-6. doi: 10.4103/0975-7406.142957.

10.

Antimicrobial screening and one-pot synthesis of 4-(substituted-anilinomethyl)-3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives.

Goel N, Drabu S, Afzal O, Bawa S.

J Pharm Bioallied Sci. 2014 Oct;6(4):253-9. doi: 10.4103/0975-7406.142956.

11.

Mini review on tricyclic compounds as an inhibitor of trypanothione reductase.

Kumar S, Ali MR, Bawa S.

J Pharm Bioallied Sci. 2014 Oct;6(4):222-8. doi: 10.4103/0975-7406.142943. Review.

12.

A review on anticancer potential of bioactive heterocycle quinoline.

Afzal O, Kumar S, Haider MR, Ali MR, Kumar R, Jaggi M, Bawa S.

Eur J Med Chem. 2015 Jun 5;97:871-910. doi: 10.1016/j.ejmech.2014.07.044. Epub 2014 Jul 24. Review.

PMID:
25073919
13.

Docking based virtual screening and molecular dynamics study to identify potential monoacylglycerol lipase inhibitors.

Afzal O, Kumar S, Kumar R, Firoz A, Jaggi M, Bawa S.

Bioorg Med Chem Lett. 2014 Aug 15;24(16):3986-96. doi: 10.1016/j.bmcl.2014.06.029. Epub 2014 Jun 19.

PMID:
25011912
14.

Synthesis and antitubercular screening of [(2-chloroquinolin-3-yl)methyl] thiocarbamide derivatives.

Kumar S, Upmanyu N, Afzal O, Bawa S.

Chem Biol Drug Des. 2014 Nov;84(5):522-30. doi: 10.1111/cbdd.12339. Epub 2014 Jun 3.

PMID:
24750991
15.

Synthesis and biological evaluation of di- and tri-substituted imidazoles as safer anti-inflammatory-antifungal agents.

Husain A, Drabu S, Kumar N, Alam MM, Bawa S.

J Pharm Bioallied Sci. 2013 Apr;5(2):154-61. doi: 10.4103/0975-7406.111822.

16.

Synthesis and pharmacological evaluation of pyrazolo[4,3-c]cinnoline derivatives as potential anti-inflammatory and antibacterial agents.

Tonk RK, Bawa S, Chawla G, Deora GS, Kumar S, Rathore V, Mulakayala N, Rajaram A, Kalle AM, Afzal O.

Eur J Med Chem. 2012 Nov;57:176-84. doi: 10.1016/j.ejmech.2012.08.045. Epub 2012 Sep 7.

PMID:
23059546
17.

Design, synthesis and screening of quinoline-incorporated thiadiazole as a potential anticonvulsant.

Kumar S, Kaushik D, Bawa S, Khan SA.

Chem Biol Drug Des. 2012 Jan;79(1):104-11. doi: 10.1111/j.1747-0285.2011.01255.x. Epub 2011 Nov 18.

PMID:
21985632
18.

Syntheses and evaluation of anti-inflammatory, analgesic and ulcerogenic activities of 1,3,4-oxadiazole and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives.

Chawla G, Kumar U, Bawa S, Kumar J.

J Enzyme Inhib Med Chem. 2012 Oct;27(5):658-65. doi: 10.3109/14756366.2011.606543. Epub 2011 Sep 8.

PMID:
21899490
19.

Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review.

Siddiqui N, Andalip, Bawa S, Ali R, Afzal O, Akhtar MJ, Azad B, Kumar R.

J Pharm Bioallied Sci. 2011 Apr;3(2):194-212. doi: 10.4103/0975-7406.80765.

20.

Synthesis and in-vitro antimicrobial activity of secondary and tertiary amines containing 2-chloro-6-methylquinoline moiety.

Kumar S, Bawa S, Kaushik D, Panda BP.

Arch Pharm (Weinheim). 2011 Jul;344(7):474-80. doi: 10.1002/ardp.201000352. Epub 2011 May 25.

PMID:
21618272

Supplemental Content

Loading ...
Support Center